Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MLANA antibody

The Mouse Monoclonal anti-MLANA antibody is suitable to detect MLANA in samples from Human, Mouse and Rat. It has been validated for WB, IF, FACS and IHC (p).
Catalog No. ABIN3026559
$640.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for MLANA antibody (ABIN3026559)

Target

See all MLANA Antibodies
MLANA (Melan A (MLANA))

Reactivity

  • 250
  • 118
  • 92
  • 38
  • 15
  • 1
Human, Mouse, Rat

Host

  • 126
  • 124
  • 1
Mouse

Clonality

  • 176
  • 75
Monoclonal

Conjugate

  • 112
  • 17
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 7
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
This MLANA antibody is un-conjugated

Application

  • 169
  • 109
  • 106
  • 105
  • 74
  • 44
  • 43
  • 26
  • 26
  • 23
  • 16
  • 12
  • 11
  • 9
  • 5
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade

Carrier-free

Clone

M2-9E3
  • Purpose

    Melan-A Antibody (azide and preservative free)

    Characteristics

    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. There are seven other melanoma associated antigens recognized by autologous cytotoxic T cells: MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MART-1 antibody labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. The antibody does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.

    Purification

    Protein G affinity chromatography

    Immunogen

    Recombinant human Melan-A protein was used as the immunogen for this antibody.

    Isotype

    IgG2b, kappa
  • Application Notes

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Melan-A antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in pH 9 10 mM Tris with 1 mM EDTA for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Preservative

    Azide free

    Storage

    4 °C,-20 °C

    Storage Comment

    Store the Melan-A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    MLANA (Melan A (MLANA))

    Alternative Name

    Melan-A

    Background

    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. There are seven other melanoma associated antigens recognized by autologous cytotoxic T cells: MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MART-1 antibody labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. The antibody does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
You are here:
Chat with us!